Exploring antibiotic resistance mechanisms in Mycobacterium abscessus for enhanced therapeutic approaches
TQ Nguyen, BE Heo, S Jeon, A Ash, H Lee… - Frontiers in …, 2024 - frontiersin.org
Mycobacterium abscessus, a leading cause of severe lung infections in
immunocompromised individuals, poses significant challenges for current therapeutic …
immunocompromised individuals, poses significant challenges for current therapeutic …
Pharmacotherapeutic considerations in the treatment of nontuberculous mycobacterial infections: A primer for clinicians
Nontuberculous mycobacteria (NTM) can cause a variety of infections, including serious
pulmonary disease. Treatment encompasses polypharmacy, with a targeted regimen of 2–5 …
pulmonary disease. Treatment encompasses polypharmacy, with a targeted regimen of 2–5 …
[HTML][HTML] Clinical characteristics and antimicrobial susceptibility profiles of Mycobacterium abscessus and Mycobacterium massiliense pulmonary infection
W Guo, Y Shangguan, Z Ji, M Hu, X Li, W Hu… - Journal of Global …, 2024 - Elsevier
Introduction Mycobacterium abscessus complex (MABC) is the most common rapidly
growing Mycobacterium species in structural pulmonary diseases and can be life …
growing Mycobacterium species in structural pulmonary diseases and can be life …